US National OCS Heart Perfusion (OHP) Registry (NCT05915299)

🧪 Interventions in This Study

• OCS Heart (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (37 Sites)

Showing the first 25 of 37 sites.

• Banner University Medical Center Phoenix — Phoenix, Arizona
• University of California San Diego — La Jolla, California
• Lucile Packard Children's Hospital Stanford — Palo Alto, California
• Stanford University — Palo Alto, California
• University of California San Francisco — San Francisco, California
• Boulder — Boulder, Colorado
• Yale New Haven Hospital — New Haven, Connecticut
• Mayo Clinic Florida — Jacksonville, Florida
• Tampa General Hospital — Tampa, Florida
• Emory University Hospital — Atlanta, Georgia
• University of Chicago — Chicago, Illinois
• University of Kentucky — Lexington, Kentucky
• Tufts Medical Center — Boston, Massachusetts
• Massachusetts General Hospital — Boston, Massachusetts
• Beth Israel Deaconess Medical Center — Boston, Massachusetts
• University of Michigan — Ann Arbor, Michigan
• Henry Ford — Detroit, Michigan
• Minneapolis Heart Institute — Minneapolis, Minnesota
• University of Minnesota — Minneapolis, Minnesota
• Mayo Clinic Rochester — Rochester, Minnesota
• Mount Sinai — New York, New York
• Columbia University Irving Medical Center/ New York Presbyterian Hospital — New York, New York
• Montefiore — The Bronx, New York
• Westchester Medical Center — Valhalla, New York
• University of North Carolina — Chapel Hill, North Carolina

📞 Contact the Study Coordinator

Phone: (978) 809-0620

Email: rhaqqi@transmedics.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Heart Transplant

• XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP) — La Jolla, California
• Randomized Trial of SGLT2i in Heart Transplant Recipients — Palo Alto, California
• Belatacept in Heart Transplantation — Los Angeles, California
• OCS DCD Heart + CAP Continued Follow-Up — La Jolla, California
• Non-invasive Prediction of EArly Cardiac rEjection — Little Rock, Arkansas

Explore by condition: All Heart Transplant clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.